Diabetes

March 5th 2024

The FLOW trial was stopped early based on an interim analysis that found the study met the criteria for efficacy.

February 13th 2024

Compared with gastric sleeve, more patients who underwent a gastric bypass surgery remained in remission from type 2 diabetes even if weight is regained.

February 7th 2024

Although most older adults support Medicare coverage of medications for weight loss drugs, only one in three favor paying more in premiums for this coverage, finds University of Michigan survey.

December 5th 2023

Zepbound, which was approved last month to treat obesity, is now available in U.S. pharmacies.